Seguir
Bapurao Surnar
Bapurao Surnar
Senior Scientist
No hay ninguna dirección de correo electrónico verificada.
Título
Citado por
Citado por
Año
Stimuli-responsive poly (caprolactone) vesicles for dual drug delivery under the gastrointestinal tract
B Surnar, M Jayakannan
Biomacromolecules 14 (12), 4377-4387, 2013
972013
Core–shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells
B Surnar, K Sharma, M Jayakannan
Nanoscale 7 (42), 17964-17979, 2015
872015
Metabolic modulation of the tumor microenvironment leads to multiple checkpoint inhibition and immune cell infiltration
D Kolb, N Kolishetti, B Surnar, S Sarkar, S Guin, AS Shah, S Dhar
ACS nano 14 (9), 11055-11066, 2020
822020
Orally administrable therapeutic synthetic nanoparticle for Zika virus
B Surnar, MZ Kamran, AS Shah, U Basu, N Kolishetti, S Deo, ...
ACS nano 13 (10), 11034-11048, 2019
652019
Enzyme and thermal dual responsive amphiphilic polymer core–shell nanoparticle for doxorubicin delivery to cancer cells
S Kashyap, N Singh, B Surnar, M Jayakannan
Biomacromolecules 17 (1), 384-398, 2016
582016
Dual-targeted synthetic nanoparticles for cardiovascular diseases
B Banik, B Surnar, BW Askins, M Banerjee, S Dhar
ACS applied materials & interfaces 12 (6), 6852-6862, 2019
392019
Targeted Mitochondrial COQ10 Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells
M Velichkovska, B Surnar, M Nair, S Dhar, M Toborek
Molecular pharmaceutics 16 (2), 724-736, 2018
392018
Dual functional nanocarrier for cellular imaging and drug delivery in cancer cells based on π-conjugated core and biodegradable polymer arms
B Kulkarni, B Surnar, M Jayakannan
Biomacromolecules 17 (3), 1004-1016, 2016
392016
Clinically approved antiviral drug in an orally administrable nanoparticle for COVID-19
B Surnar, MZ Kamran, AS Shah, S Dhar
ACS pharmacology & translational science 3 (6), 1371-1380, 2020
372020
Structural engineering of biodegradable PCL block copolymer nanoassemblies for enzyme-controlled drug delivery in cancer cells
B Surnar, M Jayakannan
ACS biomaterials science & engineering 2 (11), 1926-1941, 2016
372016
Triple block nanocarrier platform for synergistic cancer therapy of antagonistic drugs
B Surnar, M Jayakannan
Biomacromolecules 17 (12), 4075-4085, 2016
352016
Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection
B Surnar, U Basu, B Banik, A Ahmad, B Marples, N Kolishetti, S Dhar
Proceedings of the National Academy of Sciences 115 (52), E12333-E12342, 2018
342018
Polymer topology driven enzymatic biodegradation in polycaprolactone block and random copolymer architectures for drug delivery to cancer cells
M Malhotra, B Surnar, M Jayakannan
Macromolecules 49 (21), 8098-8112, 2016
342016
Halide Effects in BiVO4/BiOX Heterostructures Decorated with Pd Nanoparticles for Photocatalytic Degradation of Rhodamine B as a Model Organic Pollutant
MO Olagunju, EM Zahran, JM Reed, E Zeynaloo, D Shukla, JL Cohn, ...
ACS applied nano materials 4 (3), 3262-3272, 2021
332021
Size-Controlled SrTiO3 Nanoparticles Photodecorated with Pd Cocatalysts for Photocatalytic Organic Dye Degradation
MO Olagunju, X Poole, P Blackwelder, MP Thomas, BS Guiton, D Shukla, ...
ACS applied nano materials 3 (5), 4904-4912, 2020
262020
Brain-accumulating nanoparticles for assisting astrocytes to reduce human immunodeficiency virus and drug abuse-induced neuroinflammation and oxidative stress
B Surnar, AS Shah, M Park, AA Kalathil, MZ Kamran, R Ramirez Jaime, ...
ACS nano 15 (10), 15741-15753, 2021
232021
Biodegradable block copolymer scaffolds for loading and delivering cisplatin anticancer drug
B Surnar, PP Subash, M Jayakannan
Zeitschrift für anorganische und allgemeine Chemie 640 (6), 1119-1126, 2014
232014
A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation
RK Pathak, U Basu, A Ahmad, S Sarkar, A Kumar, B Surnar, S Ansari, ...
Biomaterials 187, 117-129, 2018
202018
Reduction of cisplatin-induced ototoxicity without compromising its antitumor activity
B Surnar, N Kolishetti, U Basu, A Ahmad, E Goka, B Marples, D Kolb, ...
Biochemistry 57 (46), 6500-6513, 2018
152018
Controlled release nanoplatforms for three commonly used chemotherapeutics
J Costoya, B Surnar, AA Kalathil, N Kolishetti, S Dhar
Molecular aspects of medicine 83, 101043, 2022
142022
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20